Professor Shanta Persaud Academics Supervisors Professor of Diabetes & Endocrinology Head, Guy’s Campus Section, School of Cardiovascular and Metabolic Medicine & Sciences. Research subject areas Diabetes Contact details shanta.persaud@kcl.ac.uk
Spatiotemporal profiling of adhesion G protein-coupled receptors in developing mouse and human pancreas reveals a role for GPR56 in islet development Mouse islet-derived stellate cells are similar to, but distinct from, mesenchymal stromal cells and influence the beta cell function Reformed islets: a long-term primary cell platform for exploring mouse and human islet biology The selective serotonin reuptake inhibitors, sertraline and paroxetine, improve islet beta-cell mass and function in vitro Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals Neuropeptide Neuromedin B does not alter body weight and glucose homeostasis nor does it act as an insulin-releasing peptide The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta-cell mass β-cell replacement therapy for type 1 diabetes: closer and closer Commiphora myrrha stimulates insulin secretion from mouse and human islets of Langerhans Diabetes basic science research takes centre stage Direct Stimulatory Effects of the CB2 Ligand JTE 907 in Human and Mouse Islets Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug In vitro profiling and functional assessments of the anti-diabetic capacity of phenolic-rich extracts of Bulbine natalensis and Bulbine frutescens Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic regulation SNAP-tag-enabled super-resolution imaging reveals constitutive and agonist-dependent trafficking of GPR56 in pancreatic β-cells Targeting islet G-protein-coupled receptors for type 2 diabetes therapy The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease A novel Gymnema sylvestre extract protects pancreatic beta-cells from cytokine-induced apoptosis Assessing Mouse Islet Function The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes Adhesion G-protein coupled receptors: Implications for metabolic function CXCL14 Inhibits Insulin Secretion Independently of CXCR4 or CXCR7 Receptor Activation or cAMP Inhibition Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug. GPCR targets in type 2 diabetes The association between selective serotonin reuptake inhibitors and glycemia: a systematic review and meta-analysis of randomized controlled trials Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets Editorial overview: Endocrine and metabolic diseases Druggable diabetes: identification of therapeutic opportunities Identifying novel therapeutic targets for diabetes through improved understanding of islet adhesion receptors Identifying signalling pathways regulated by GPRC5B in β-cells by CRISPR-Cas9-mediated genome editing LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling. Mesenchymal stromal cell secretory factors induce sustained improvements in islet function pre- and post-transplantation Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2 The adhesion receptor GPR56 is activated by extracellular matrix collagen III to improve β-cell function The Placental Secretome: Identifying Potential Cross-Talk between Placenta and Islet β-Cells A comparative analysis of human and mouse islet G-protein coupled receptor expression Anti-diabetic action of all-trans retinoic acid and the orphan G protein coupled receptor GPRC5C in pancreatic β-cells C3aR and C5aR1 act as key regulators of human and mouse β-cell function Dynamic Profiling of Insulin Secretion and ATP Generation in Isolated Human and Mouse Islets Reveals Differential Glucose Sensitivity Islet G-protein coupled receptors: therapeutic potential for diabetes Islet neuropeptide Y receptors are functionally conserved and novel targets for the preservation of beta-cell mass The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. The monounsaturated fatty acid oleate is the major physiological toxic free fatty acid for human beta cells Annexin A1 Is a Key Modulator of Mesenchymal Stromal Cell-Mediated Improvements in Islet Function APT070 (Mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model A wake-up call for type 2 diabetes? Can we make a better beta cell? Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential Fine tuning of insulin secretion by release of nerve growth factor from mouse and human islet β-cells View all publications
7 December 2023 £4.8 million awarded to King's scientists to help find cure for type 1 diabetes Two major research projects, led by Professor Shanta Persaud and Dr Aileen King, and Professor…